| Michael James Wilwand, DO | |
|
55 West Tietan Street, Walla Walla, WA 99362-4445 | |
| (509) 525-3720 | |
| (509) 522-1592 |
| Full Name | Michael James Wilwand |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 22 Years |
| Location | 55 West Tietan Street, Walla Walla, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861604217 | NPI | - | NPPES |
| 0233966 | Other | WA | L & I |
| 8518730 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 5101015498 (Michigan) | Secondary |
| 207X00000X | Orthopaedic Surgery | OP00002294 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Mary Medical Center | Walla walla, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Washington Pllc | 2264320837 | 51 |
News Archive
Schering-Plough Corporation has announced that it has extended to stage two an ongoing Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. In this study, vicriviroc is being evaluated in a novel nucleoside-sparing regimen that is designed to provide additional options for treatment-naive patients in a once daily regimen, while preserving other drug classes for subsequent lines of treatment.
Zits, pimples, bumps and blemishes are a young person's worst nightmare. Collectively they are known as acne, a very common skin condition that affects millions of adolescents. Now a Norwegian study published in the open access journal BMC Public Health has investigated the links between acne, diet and mental health issues in both males and females.
In a study with mice reported today in the journal Science Translational Medicine, a Johns Hopkins Medicine research team has provided what may be the most definitive view to date of the biological process leading to necrotizing enterocolitis (NEC), a dangerous inflammatory disease that can destroy a premature infant's intestinal lining and causes death in up to a third of the cases.
North Bay (Santa Rosa, Calif.) Business Journal: "While community health centers are widely seen as winners with the passage of a sweeping health bill in late March, such centers in California face potentially crippling state budget cuts, which could offset potential gains that won't take effect until 2014, according to clinic directors throughout the North Bay.
› Verified 7 days ago
| Entity Name | Privia Medical Group Washington Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780658419 PECOS PAC ID: 2264320837 Enrollment ID: O20040309000126 |
News Archive
Schering-Plough Corporation has announced that it has extended to stage two an ongoing Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. In this study, vicriviroc is being evaluated in a novel nucleoside-sparing regimen that is designed to provide additional options for treatment-naive patients in a once daily regimen, while preserving other drug classes for subsequent lines of treatment.
Zits, pimples, bumps and blemishes are a young person's worst nightmare. Collectively they are known as acne, a very common skin condition that affects millions of adolescents. Now a Norwegian study published in the open access journal BMC Public Health has investigated the links between acne, diet and mental health issues in both males and females.
In a study with mice reported today in the journal Science Translational Medicine, a Johns Hopkins Medicine research team has provided what may be the most definitive view to date of the biological process leading to necrotizing enterocolitis (NEC), a dangerous inflammatory disease that can destroy a premature infant's intestinal lining and causes death in up to a third of the cases.
North Bay (Santa Rosa, Calif.) Business Journal: "While community health centers are widely seen as winners with the passage of a sweeping health bill in late March, such centers in California face potentially crippling state budget cuts, which could offset potential gains that won't take effect until 2014, according to clinic directors throughout the North Bay.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael James Wilwand, DO 55 West Tietan Street, Walla Walla, WA 99362-4445 Ph: (509) 525-3720 | Michael James Wilwand, DO 55 West Tietan Street, Walla Walla, WA 99362-4445 Ph: (509) 525-3720 |
News Archive
Schering-Plough Corporation has announced that it has extended to stage two an ongoing Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. In this study, vicriviroc is being evaluated in a novel nucleoside-sparing regimen that is designed to provide additional options for treatment-naive patients in a once daily regimen, while preserving other drug classes for subsequent lines of treatment.
Zits, pimples, bumps and blemishes are a young person's worst nightmare. Collectively they are known as acne, a very common skin condition that affects millions of adolescents. Now a Norwegian study published in the open access journal BMC Public Health has investigated the links between acne, diet and mental health issues in both males and females.
In a study with mice reported today in the journal Science Translational Medicine, a Johns Hopkins Medicine research team has provided what may be the most definitive view to date of the biological process leading to necrotizing enterocolitis (NEC), a dangerous inflammatory disease that can destroy a premature infant's intestinal lining and causes death in up to a third of the cases.
North Bay (Santa Rosa, Calif.) Business Journal: "While community health centers are widely seen as winners with the passage of a sweeping health bill in late March, such centers in California face potentially crippling state budget cuts, which could offset potential gains that won't take effect until 2014, according to clinic directors throughout the North Bay.
› Verified 7 days ago
Dr. Erik C Gryler, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 W Tietan St, Walla Walla, WA 99362 Phone: 509-525-3720 Fax: 509-522-1573 | |
Dr. Richard Lyle Henderson, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 Chase Ave, Orthopedics, Walla Walla, WA 99362 Phone: 509-522-5820 Fax: 509-522-5570 | |
Mr. Michael Wade Gillespie, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 101 Brookside Drive, Walla Walla, WA 99362 Phone: 509-525-1890 | |
Kirk Ellsworth Willard, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 Chase Ave, Orthopaedics, Walla Walla, WA 99362 Phone: 509-522-5820 Fax: 509-522-5570 | |
Scott B Hutson, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1017 S 2nd Ave, Suite 1, Walla Walla, WA 99362 Phone: 509-525-4900 Fax: 509-522-3886 |